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Abstract
We have investigated species-specific isotope dilution mass spectrometry (IDMS) for the
quantification of ferritin-bound iron in murine serum and brain. Therefore, fresh samples were
analyzed using size exclusion chromatography inductively coupled plasma mass spectrometry
(SEC-ICP-MS). Isotopically labeled (57Fe)ferritin was used as calibrant for the quantification of
ferritin-bound iron in murine samples. Assessment of the iron load of serum ferritin was
impaired by concomitant iron-containing proteins of similar size and shape, which could not be
separated by SEC nor centrifugal ultra-filtration. In contrast, ferritin was the main
iron-containing protein in cytosolic extracts of murine brain, which showed a total ferritin-bound
iron content of (1.05 ± 0.12) µg g−1 (n = 10; U, k = 2). The relative expanded uncertainty
achieved for a mass fraction of ca. 1 µg g−1 ferritin-bound iron was 11% (Urel, k = 2). The
relative expanded uncertainty of the iron mass fraction of the (57Fe)ferritin spike was 5.7% and
represented the major contributing factor to the overall uncertainty. Statistical tests suggested no
significant difference in ferritin-bound iron content between mouse brain hemispheres. The
presented analytical tool provides low limits of quantification (2.2 ng g−1) and uncertainties
(11%, Urel, k = 2), thus enables the quantification of ferritin-bound iron in murine brain extracts
with high sensitivity and accuracy. Furthermore, this analytical workflow assures comparability
of measurement results across research laboratories. This provides the basis for investigation of
the iron loading of ferritin in brain tissue of healthy and Alzheimer’s disease mouse models,
which may help answering the question if iron regulation is impaired in Alzheimer’s disease.
Keywords: neurodegenerative diseases, metalloproteins, iron metabolism, measurement
uncertainty budget
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1. Introduction
The Alzheimer’s disease (AD) is a neurodegenerative disease,
which affectsmillions of people worldwide [1]. The symptoms
of AD are well described. However, the fundamental mechan-
isms of AD as well as reliable diagnostic tools are still sub-
ject of active research [1]. One hypothesis suggests that AD
is a result of dysregulation of iron homeostasis in brain [2, 3].
In particular, it is believed that ferritin (FER), the major iron
storage protein in cells [4], cannot fulfill its regulatory func-
tion. This leads to an excess of free iron (Fe2+), a chemical
form which can cause oxidative stress and cell damage [5].
To investigate this hypothesis, solid knowledge on FER-bound
iron levels in healthy and AD brain are required. In addition,
it is suggested that damaged cells release FER to serum [6].
Thus, when the iron contents of brain and serum FER cor-
relate, the latter might represent a highly promising new bio-
marker for AD.
Quantification of FER-bound iron in brain and serum is
not trivial. FER needs to be extracted from brain in its intact
form to avoid disruption of the protein shell and loss of FER-
bound iron. Furthermore, the amount of FER varies across tis-
sues and fluids [7, 8]. Finally, FER shows variable iron load-
ing, which can range from no to several thousand iron atoms
per molecule [9]. Consequently, analysis of FER-bound iron
in brain and serum requires an instrumental technique, which
provides sensitivity, selectivity and a large dynamic range.
Moreover, to draw conclusions as to the role of FER in AD,
measurement results have to be as accurately as possible and
comparable across measurement systems, location and time.
These specific requirements are fulfilled by the combina-
tion of inductively coupled plasma mass spectrometry (ICP-
MS) and species-specific isotope dilution mass spectrometry
(IDMS). ICP-MS is an instrumental technique, which offers
detection limits down to fg g−1 levels and a dynamic range
of more than nine orders of magnitude [10]. Furthermore, an
important feature of ICP-MS is its capability to be coupled
to liquid chromatographic (LC) systems [11], which allows
online separation of FER from concomitant iron containing
proteins prior to elemental analysis. Species-specific IDMS
is the most accurate analytical tool for the quantification of
the elemental content of proteins [12]. It uses an isotopically
labeled analogue of the protein of interest as calibrant, which
is mixed with the sample at the start of the sample prepara-
tion. Subsequently, the analyte-calibrant mixture is purified
and mass spectrometrically analyzed. An additional feature of
this calibration technique is that the analyte and calibrant are
equally affected by e.g. instrumental drifts, species instabilit-
ies or sample loss. Accordingly, these effects are inherently
corrected for, thus do not influence the final results [12]. Fur-
thermore, when a certified reference material is used as spike
material or as calibration material in double IDMS, species-
specific IDMS ensures that the measurement results are trace-
able to an SI unit (e.g. kg) though an unbroken calibration
chain [13, 14]. This guarantees that analytical results are com-
parable independently of time, location and operator [14].
This procedure was successfully applied for the quantifica-
tion of FER-bound iron in human serum [15]. However, the
most common model organisms for AD research are mice.
They provide only a few 100 µl of serum compared to mL
amounts available from humans. Furthermore, to the best of
our knowledge, no species-specific IDMS quantification of
FER-bound iron in murine brain has been performed yet.
Thus, the aim of this pilot study was to investigate the
applicability of species-specific IDMS for the quantification
of FER-bound iron in murine serum and brain tissue. Fur-
thermore, we examined if the FER-bound iron content differs
between brain hemispheres and evaluated the uncertainty of
the analytical procedure.
2. Experimental
2.1. Reagents and methods
Preparatory work and elemental analysis were carried out at
the University of Vienna, Department of Analytical Chem-
istry in an ISO class 8 clean room according to ISO 14 644-
1. Aqueous solutions were prepared using ultrapure water
(18 MΩ cm, Veolia Water Solutions, France). Per analysis
nitric acid (HNO3, 69% w/w) was purchased from Merck,
Germany. Supra pure-quality HNO3 (69% w/w) and hydro-
chloric acid (HCl, 35% w/w) were purchased from Carl Roth,
Germany. Equine spleen FER and apo-FER, human plasma
transferrin and equine skeletal muscle myoglobin were pur-
chased from Sigma Aldrich, USA. An ammonium acetate
buffer 50 mM was prepared by addition of ammonia (25%,
supra pure, Avantor, USA) to ultrapure water and adjusting
the pH to 6.8 using acetic acid (100%, suprapure, Carl Roth,
Germany). A 20-fold concentrated extraction buffer (TRIS
buffered saline) containing 1 M TRIS-HCl (100%, ultrapure,
Gerbu, Germany; HCl: Carl Roth; pH 7.6) with 3.08M sodium
chloride (NaCl, 99.99%, supra pure, Merck, Germany) in
ultrapure water was prepared. Tween 20 (Bio-Rad, USA) was
diluted tenfold. Final lysis buffer contained 0.5 ml of TRIS
buffer saline, 0.05 ml of diluted Tween 20 and 9.45 ml of
ultrapure water. All laboratory consumables (polyethylene
tubes, pipette tips, etc) were washed using 10% HNO3 (w/w,
Merck) followed by 1% HNO3 (w/w, Carl Roth) and ultrapure
water before use. All dilutions were performed gravimetric-
ally.
2.2. Preparation of calibrants for (reverse) isotope dilution
mass spectrometry
Isotopically enriched iron metal powder with a 57Fe isotopic
abundance of 95.08% (Eurisotope, France) was dissolved
using conc. HCl in a PFA beaker on a hot plate. The solution
was evaporated to dryness and diluted using 5% HCl (w/w)
to obtain a 57FeCl2 solution of ca. 2000 µg g−1 total Fe con-
tent. A native FER standard (equine spleen, Sigma Aldrich,
Lot Num. SLBMO474 V) was divided into five aliquots of ca.
50 mg and microwave-assisted (Multiwave Pro, Anton Paar,
Austria) acid digested using a reaction mixture of 2 ml of 20%
HNO3 (w/w) and 0.1 ml of H2O2 (30% w/w, ultrapure, Merck,
Germany). Digested samples were diluted to 4% HNO3 (w/w)
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using ultrapure water. Isotopically labeled FER was synthes-
ized using a modified version of the protocol by Konz et al
[15]. Apo-FER (Sigma Aldrich) was diluted with ammonium
acetate buffer 50 mM pH 6.8 to a volume of 2 ml resulting in a
500 µg g−1 protein solution and mixed with 57FeCl2 solution
(125 µl, 2000 µg g−1 total Fe content in 5% HCl w/w). The
solution was then vortexed for 1 min (Vortex V-1 plus, Biosan
SIA, Latvia) and incubated at room temperature for 1 h. Cent-
rifugal ultra-filtration facilitated the purification of synthes-
ized (57Fe)FER from residual free 57Fe. Therefore, membrane
filters with a cut-off value of 100 kDa (Amicon Ultra-0.5 ml,
Merck, Germany) were washed (3× 5% HNO3 w/w, 3x ultra-
pure water) and conditioned by centrifugation of 500 µl of
ammonium acetate buffer 50 mM pH 6.8 (15 000 g, 10 min,
4 ◦C, Microliter Centrifuge, HERMLE Labortechnik GmbH,
Germany) prior to use. The mixture was loaded on the fil-
ter, centrifuged (15 000 g, 30 min, 4 ◦C, Microliter Centri-
fuge) and washed three times using ammonium acetate buffer
50mMpH6.8. The purified (57Fe)FERwas stored in the fridge
at 4 ◦C until use. (For the analysis of the purity and the iron
content of the (57Fe)FER spike see paragraph ‘Instrumenta-
tion’ and ‘Quantification of iron content by (reverse) isotope
dilution mass spectrometry’ below.)
2.3. Sample collection
Two male 18-weeks old Balb/c mice (purchased from Envigo,
Italy) were anesthetized with rompun/ketavet and blood was
collected by heart puncture followed by sacrifice via cervical
dislocation. The blood samples were allowed to clot in con-
ventional Eppendorf tubes at room temperature (~25 min) and
separated into serum and pellet by centrifugation (2x 900 g for
10 min at 4 ◦C). In addition, the brain of one mouse was col-
lected during dissection, cooled on ice and (together with the
serum) immediately (within 10 min) used for the experiments
without further processing.
2.4. Sample preparation
Murine serums were vortexed (Biosan SIA). The serum
sample of one mouse (ca. 100 µl) was used as such. The serum
sample of the second mouse (ca. 500 µl) was divided into
two aliquots: (1) One aliquot of 30 µl was used as such. (2)
The second aliquot of ca. 470 µl was subjected to centrifu-
gal ultra-filtration. Ren and Walczyk proposed this procedure
for off-line FER fractionation from other iron containing pro-
teins [16]. Therefore, 470 µl of undiluted murine serum were
applied on preconditioned membrane filters (100 kDa, Ami-
con; see above), centrifuged (15 000 g, 1 h, 4 ◦C, Microliter
Centrifuge) and washed three times using ammonium acetate
buffer 50mMpH6.8. Themurine brain was placed in a dispos-
able plastic cup and divided in two hemispheres using a plastic
spatula. Brain extracts were prepared following a modified
procedure for the extraction of cytosolic proteins developed by
the University of Aberdeen, Department of Chemistry. Each
hemisphere (ca. 200 mg) was transferred into a separate 2 ml
low binding tube, mixed with 1 ml of freshly prepared ice-
cold lysis buffer (see above) and homogenized manually using
a plastic spatula for 5 min on ice. The extracts were centri-
fuged (15 000 g, 20 min, 4 ◦C, Microliter Centrifuge) and the
supernatant solutions transferred into separate tubes stored on
ice, respectively. The extraction procedure was repeated two
times. All samples were measured within 24 h after harvest.
2.5. Instrumentation
Digested samples and native proteins were diluted as required
and analyzed for their iron content using a triple quadru-
pole ICP-MS (Agilent 8800, Agilent Technologies, USA)
equipped with a Scott double-pass spray chamber (Agilent,
USA). Iron isotopeswere assessed in reactionmode (30%oxy-
gen) at mass-to-charge ratios of 54Fe16O, 56Fe16O, 57Fe16O
and 58Fe16O, respectively. An autosampler (ASX-500, Agi-
lent, USA) facilitated direct injection of mineralized solu-
tions (Fe single element standard, 57FeCl2 solution, diges-
ted equine spleen FER) into the ICP-MS. Analysis of the
iron content of intact proteins (native equine spleen FER, nat-
ive (57Fe)FER spike, native murine serum and brain extracts)
was accomplished by size exclusion chromatography ICP-
MS (SEC-ICP-MS). For this a LC system (1260 Infinity Bio-
Inert, Agilent Technologies, USA) was used as sample intro-
duction system. The sample volume accounted to 5 µl and
the flow rate of the ammonium acetate buffer 50 mM pH
6.8 used as mobile phase to 200 µl min−1. Subsequently, a
SEC column (MabPac, Thermo Fisher Scientific, USA) separ-
ated iron-containing proteins according to their hydrodynamic
volume followed by elemental analysis with ICP-MS (Agilent
8800). Table 1 summarizes the instrumental conditions used
for the determination of the total iron content of mineralized
samples and the iron load of intact FER (Fe:FER; quantific-
ation of the iron content was performed by (reverse) IDMS,
see paragraph ‘Quantification of iron content by (reverse) iso-
tope dilution mass spectrometry’ below). The limit of quan-
tification (LOQ) of the direct injection method accounted to
ten times the standard deviation of the process blank quanti-
fied using a 5-point calibration (Fe single element standard,
LabKings, The Netherlands). The LOQ of the SEC-ICP-MS
method was determined following EURACHEM guidelines
[17] as equivalent of ten times the standard deviation of the
lowest detectable measurement standard of a 5-point equine
spleen FER calibration (Sigma Aldrich). The quantification
of the sulphur content of FER was focus of the Physikalisch-
Technische Bundesanstalt (PTB) and will be discussed in a
follow-up publication.
2.6. Quantification of iron content by (reverse) isotope
dilution mass spectrometry
IDMS is an established primary method of highest metrolo-
gical order, which facilitates the accurate and traceable quan-
tification of analyte content at ng g−1 levels [13]. Theoret-
ical considerations are described in detail elsewhere [18]. The
IDMS workflow in this study comprised four steps:
(a) Quantification of the total Fe content of the isotopic-
ally enriched 57FeCl2 solution by direct injection reverse
3
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Table 1. Instrumental and method parameters for the determination of the iron content of digested samples and native proteins by ICP-MS
operated in reaction mode.
Direct injection ICP-MS SEC-ICP-MS
Sample introduction peristaltic pump LC system
Sample volume 2 ml 5 µl
Flow rate pump speed 0.3 rps 200 µl min−1
Mobile phase — 50 mM CH3COONH4, pH 6.8
Column — MabPac SEC, PEEK, 4 × 300 mm, 5 µm, 10–1000 kDa
Nebulizer MicroFlow PFA-ST MicroFlow PFA-ST
Spray chamber Scott double-pass Scott double-pass
Nebulizer gas flow 1.07 l min−1 1.07 l min−1
Auxilary gas flow 0.90 l min−1 0.90 l min−1
Plasma gas flow 15 l min−1 15 l min−1
ICP RF power 1550 W 1550 W
Cones Ni Ni
Reaction gas Oxygen (30%) Oxygen (30%)
Analytes 54Fe16O, 56Fe16O, 57Fe16O, 58Fe16O 54Fe16O, 56Fe16O, 57Fe16O, 58Fe16O
Integration time 0.30 s 0.10 s
LOQ(Fe) 0.05 ng g−1 2.2 ng g−1
IDMS using an Fe standard (LabKings) with a certified
elemental content traceable to NIST SRM 3126;
(b) Quantification of the total Fe content of digested equine
FER (Sigma Aldrich) by direct injection IDMS using
the isotopically enriched 57FeCl2 solution characterized in
step 1;
(c) Quantification of FER-bound iron in intact isotopically
labeled (57Fe)FER by species-specific reverse IDMS using
intact equine FER (Sigma Aldrich) characterized in step 2;
(d) Quantification of FER-bound iron in intact murine FER
by species-specific IDMS using intact isotopically labeled
(57Fe)FER characterized in step 3.
This unbroken calibration chain links the measured iron
content of intact murine FER to the certified iron content of the
NIST SRM 3126. This certified reference material represents
a primary calibration standard and its certified mass fraction is
metrologically traceable to the SI unit of mass. As the aim of
this pilot studywas to evaluate if species-specific IDMS is suit-
able for quantification of FER-bound iron in murine samples
relevant to study the mechanisms of AD, this calibration hier-
archy was considered fit-for-intend-use. If this method is used
for future provision of calibration services the NIST SRM
3126 or a material certified by a National Metrology Institute
should be used.
Equation (1) enables the calculation of the Fe content wy
in the isotopically enriched calibrants (step 1 and 3 above).
The Fe content wx of equine and murine FER was assessed by
equation (2) (step 2 and 4 above). Equations are from [18].
wy = wx · mxmy ·
My
Mx
· A
56
x
A57y
·
(
1− 56Fe/57Femix · 57Fe/56Fex
56Fe/57Femix− 56Fe/57Fey
)
(1)
wx = wy · mymx ·
M x
My
· A
57
y
A56x
·
( 56Fe/57Femix − 56Fe/57Fey
1− 56Fe/57Femix · 57Fe/56Fex
)
.
(2)
Here, x denotes samples with a natural isotopic compos-
ition of iron, y samples with an isotopically enriched iron
composition and mix the sample-calibrant blend. The masses
m were assessed using a microbalance (CPA225D, Sartorius,
Germany). All stable isotope ratios of iron, iFe/jFe where i > j,
were determined experimentally. Mass bias correction was
omitted as all isotope ratios were measured under the same
experimental conditions [19] and used for the calculation of
the isotopic abundances A of iron in the samples. The atomic
weightsM were calculated using experimentally assessed iso-
topic abundances A and atomic masses of iron according to
Berglund and Wieser [20].
2.7. Uncertainty evaluation
The uncertainty indicates the quality of analytical results and
enables their comparison independent of the applied analyt-
ical method, time and location [21]. Thus, the measurement
uncertainty goes hand in hand with metrological traceability.
All uncertainties in this study were determined in a Kragten
approach [22] following EURACHEM guidelines [21]. Each
sample solution was analyzed five-times. The assessed mean
and the standard deviation (SD) were used as input parameters
in the model equation (equations (1) and (2), see above) for
the determination of the combined measurement uncertainty.
Evaluation of sample homogeneity was performed by prepar-
ing and measuring five individual sample-calibrant blends.
The expanded uncertainty (U, k= 2) in this work corresponds
to the combination of the contribution of the measurement
uncertainty and the sample homogeneity multiplied by a cov-
erage factor k of 2.
2.8. Statistical analysis
A boxplot visualized the content of FER-bound iron in mouse
brain hemispheres. A Kolmogorov-Smirnov test showed
normal distribution and a Levene test equal variances of
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Figure 1. Equine spleen ferritin 0.010 mg g−1 (weight of protein
shell ca. 440 kDa), human plasma transferrin 1.0 mg g−1 (ca.
72 kDa) and equine skeletal muscle myoglobin 0.10 mg g−1 (ca.
17 kDa) protein standards separated by SEC; iron was measured as
56Fe16O using ICP-MS.
FER-bound iron content in mouse brain extracts. Con-
sequently, an independent sample t-test was used to determine
significant differences of FER-bound iron content in extracts
of mouse brain hemispheres. The statistical significance level
corresponded to α = 0.05. Statistical data evaluation was
performed using SPSS© (IBM SPSS Statistics 24, Armonk,
USA).
3. Results and discussion
3.1. Method suitability for ferritin-bound iron quantification
Species-specific IDMS is an accurate analytical method,
which can determine the iron loading of FER in complex bio-
logical matrixes. Therefore, it requires: (i) The separation of
intact FER from concomitant iron-containing proteins, (ii) the
measurement of the isotopic composition of iron in FER and
(iii) a well characterized isotopically labeled FER spike used
as calibrant for the quantification of FER-bound iron.
Figure 1 shows FER, transferrin and myoglobin standards
separated by SEC and eluting Fe measured by ICP-MS. Two
thirds of FER were present in the monomeric form (peak at
retention time of 10.0 min) and one third in the form of oli-
gomers (peaks at retention time of 7.2–9.2 min). These find-
ings were in accordance with studies by Konz et al [15]. They
suggested that oligomerization occurs as a result of high FER
content and the presence of free Fe2+, which might reduce
disulphide bonds on the surface of the protein monomers [15].
Consequently, to account for the entire iron load of FER, the
combined peak areas of FER monomers and oligomers were
used for further data evaluation hereafter.
The LOQ of FER-bound iron accounted to 2.2 ng g−1 (table
1). FER protein levels in serum of healthy mice range from
Figure 2. SEC chromatogram of the isotopically labeled (57Fe)FER
spike (ca. 4 µg g−1 FER-bound iron); black line corresponds to the
56Fe16O trace and dotted line to the 57Fe16O trace.
170 to 438 ng ml−1 [23, 24]. This is comparable to human
serum FER protein levels of 1–800 ng ml−1, which showed
FER-bound iron content of 3–77 ng g−1 [16, 25]. Assuming
similar iron loading of murine and human FER, the low LOQ
of the presented protocol facilitates FER-bound iron analysis
of murine samples without enrichment.
The chromatographic profile of the isotopically labeled
(57Fe)FER spike shows that FER was solely present in the
monomeric form (figure 2). Repeated measurements of the
spike showed that it was stable for over 6 months after pro-
duction.
Species-specific reverse IDMS using an intact equine
spleen FER standard, with a well characterized iron load of
the native protein, as calibrant (see paragraph ‘Quantification
of iron content by (reverse) isotope dilution mass spectro-
metry’, step 3, above) revealed that FER-bound iron content of
the synthesized isotopically enriched (57Fe)FER amounted to
(3.87± 0.32) µg g−1 (n= 5;U, k= 2; table 2). Calculation of
the relative isotopic abundances of the synthesized (57Fe)FER
showed that 57Fe accounted for about 95% of FER-bound iron.
This result was in accordance with the isotopic composition of
the isotopically enriched iron used for apo-FER loading and
suggested successful isotopic labeling of FER.
These results indicated that the proposed analytical meth-
odology is fit-for-purpose of FER-bound iron quantification in
murine serum and brain samples.
3.2. Method application to murine serum
Figure 3 shows the SEC chromatogram of fresh murine serum.
Surprisingly, no characteristic FER peaks could be observed.
Instead, the chromatogram shows unspecific signals at reten-
tion time of 8–12 min. This observation was confirmed by
SEC-ICP-MS analysis of the second serum sample (500 µl;
5
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Figure 3. SEC chromatogram of fresh mouse serum shows unspecific peaks at retention times of 8–12 min; iron was monitored as 56Fe16O.
Figure 4. SEC chromatogram of fresh undiluted mouse brain
extract; black line corresponds to the 56Fe16O trace and dotted line
to the 57Fe16O trace.
see chapter ‘Samples’ above). These findings suggested co-
elution of FER and concomitant iron containing proteins,
which were present in the serum sample. A subsequent iron
and sulfur SEC-ICP-MS analysis of a FER and transferrin
standard mixture suggested that these species might be trans-
ferrin oligomers.
To remove interfering iron containing proteins, we
subjected an aliquot of the second serum sample to centrifugal
ultra-filtration prior to SEC-ICP-MS analysis. However, this
purification attempt failed as neither centrifugal ultra-filtration
Figure 5. Fresh mouse brain extract was mixed with isotopically
enriched (57Fe)FER from equine spleen (ca. 4 µg g−1 FER-bound
iron) to achieve equal height of FER-bound iron peaks; black line
corresponds to the 56Fe16O trace and dotted line to the 57Fe16O trace.
nor size exclusion chromatography can separate proteins of
similar size and shape.
This problem could be overcome by a combination of
chemical and size-based separation techniques. For example,
Konz et al showed effective purification of intact FER from
human serum by methanol and heat precipitation prior to cent-
rifugal ultra-filtration and SEC-ICP-MS analysis [25]. How-
ever, this multi-step purification procedure is time consuming
and FER recoveries accounted for 40%. Furthermore, murine
6
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Figure 6. Boxplot of FER-bound iron (Fe:FER) content of extracts
of mouse brain hemispheres determined by species-specific IDMS
(n = 5); whiskers correspond to minimum and maximum
FER-bound iron values.
serum is available only in limited amount of a few 100 µl in
comparison to 1.5 ml human serum used by Konz et al [25].
Consequently, major loss of FER might result in FER-bound
iron levels being below LOQ. Thus, quantification of FER-
bound iron in murine serum by species-specific IDMSwas not
considered further.
3.3. Method application to murine brain extract
The SEC chromatogram of fresh murine brain extract showed
a pronounced FER peak at retention time of 10.0 min
(figure 4). Furthermore, in contrast to murine serum, iron con-
taining matrix proteins did not interfere with the FER signal.
Thus, it was possible to apply species-specific IDMS for FER-
bound iron quantification in murine brain extracts.
Figure 5 shows the 56Fe16O and 57Fe16O trace of
murine brain extract spiked with (57Fe)FER, which rep-
resented the calibrant for FER-bound iron quantification.
Species-specific IDMS revealed a FER-bound iron content of
(1.03 ± 0.11) µg g−1 and (1.07 ± 0.12) µg g−1 in extracts
of mouse brain hemispheres (n = 5; U, k = 2), respectively.
These results overlapped within limits of uncertainty. Thus,
according to EURACHEM guidelines they have to be con-
sidered equal [21]. This result was additionally confirmed by
an independent t-test and illustrated by a boxplot diagram (fig-
ure 6). Consequently, these findings suggested no signific-
ant difference in FER-bound iron content between extracts of
brain hemispheres of the investigated control mouse.
These results represent a first step towards the application
of species-specific IDMS for FER-bound iron quantification in
murine samples relevant for AD studies. It is also of interest
to note that FER seems to be the major iron containing protein
in brain cytosol extracts, which is in strong contrast to serum.
Table 2. Content of total Fe and FER-bound iron in calibrants and
mouse brain extracts determined by (reverse) IDMS; uncertainties
correspond to U, k = 2; significant numbers of digits are given
according to EURACHEM guidelines.
Solution Replicates Unit Fe U Urel
Fe standard n = 5 mg g−1 1.0000 0.0030 0.30%
57FeCl2 solution n = 5 mg g−1 1.952 0.026 1.3%
FER standard n = 5 mg g−1 10.8 0.6 5%
(57Fe)FER n = 5 µg g−1 3.87 0.32 8%
Brain extract n = 10 µg g−1 1.05 0.12 11%
3.4. Uncertainty contributors to ferritin-bound iron content
In this study, the reported uncertainty comprised the combined
measurement uncertainty and the sample homogeneity. The
first component takes all sources of error of the measurement
procedure into account. The second component corresponds to
the reproducibility, i.e. the variation of FER-bound iron con-
tent in murine brain extracts.
The gross mean of FER-bound iron content in murine brain
extracts accounted for (1.05± 0.12) µg g−1 (n= 10;U, k= 2;
table 2). Thus, species-specific IDMS facilitated to achieve a
relative expanded uncertainty of 11% (Urel, k= 2). The uncer-
tainty of the iron elemental content of the (57Fe)FER spike rep-
resented the major contribution to the combined uncertainty.
It accounted to a relative expanded uncertainty of 5.7% and
was a consequence of the applied multi-step calibration pro-
cedure (table 2; Note: The relative uncertainty of the result is
always greater than the uncertainty of the calibrant used for
quantification.). The contribution of the sample homogeneity
to the expanded uncertainty accounted for 4.7% (Urel, k = 2).
This value corresponds to 2RSD of the determined FER-bound
iron content in mouse brain extracts. Other uncertainty sources
such as the weights of the sample and the spike, the atomic
weights, the isotope ratios, etc contributed to 0.6% of the relat-
ive expanded uncertainty of FER-bound iron content in mouse
brain extracts.
4. Conclusion
The investigation of fundamental mechanisms of the
Alzheimer’s disease calls for sophisticated methods cap-
able of delivering accurate and comparable results. Species-
specific IDMS facilitated the determination of FER-bound
iron in cytosolic extracts of murine brain, which accounted
for (1.05 ± 0.12) µg g−1 (n = 10; U, k = 2). The achieved
low LOQ of 2.2 ng g−1 and relative expanded uncertainty of
11% (Urel, k = 2) obtained for a mass fraction of ca. 1 µg g−1
iron in FER are suitable for determining differences in FER-
bound iron content of brain extracts of healthy and AD mice.
Furthermore, using this method analytical results are trace-
able to the SI unit kg through an unbroken calibration chain.
This ensures comparability of FER-bound iron levels across
research centers. This methodology provides the basis for
deepening our understanding of the role of FER in the onset
7
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and progress of Alzheimer’s disease. In future, it could poten-
tially serve as a reference method in (pre)clinical Alzheimer’s
disease studies. These metrological measures will enable to
combine and compare large numbers of analytical results from
different research laboratories all over the world.
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